Accel Wealth Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$149K 247
2024
Q1
$149K Hold
10,000
0.06% 221
2023
Q4
$179K Hold
10,000
0.09% 189
2023
Q3
$191K Hold
10,000
0.11% 162
2023
Q2
$159K Hold
10,000
0.09% 166
2023
Q1
$174K Hold
10,000
0.07% 238
2022
Q4
$169K Hold
10,000
0.08% 175
2022
Q3
$136K Hold
10,000
0.07% 209
2022
Q2
$105K Hold
10,000
0.06% 228
2022
Q1
$136K Hold
10,000
0.07% 210
2021
Q4
$132K Sell
10,000
-306
-3% -$3.85K 0.06% 220
2021
Q3
$82K Hold
10,306
0.05% 252
2021
Q2
$71K Hold
10,306
0.05% 281
2021
Q1
$63K Hold
10,306
0.05% 281
2020
Q4
$32K Buy
+10,306
New +$35.9K 0.03% 391

Other funds holding CLMT

Accel Wealth Management's CLMT Position: Q2 2024 in Review

Accel Wealth Management sold out of Calumet Specialty Products (CLMT) in Q2 2024, closing a stake of 10,000 shares — an estimated $149K sold.

Accel Wealth Management first reported a position in CLMT in Q4 2020 and held it in 14 quarters. The position peaked at $191K in Q3 2023. 69 funds tracked by Wall St. Rank hold CLMT as of Q2 2024.

  • Accel Wealth Management reported no remaining Calumet Specialty Products position as of Q2 2024 after selling out during the quarter.
  • Accel Wealth Management sold 10,000 Calumet Specialty Products shares in Q2 2024, an estimated $149K.
  • Accel Wealth Management first reported a position in Calumet Specialty Products in Q4 2020 and held it in 14 quarters.
  • Accel Wealth Management's Calumet Specialty Products position peaked at $191K in Q3 2023.
  • 69 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2024.

Based on Accel Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.